Literature DB >> 18399434

The use of HET-CAM test in detecting the ocular irritation.

J Tavaszi1, P Budai.   

Abstract

Agrochemicals must undergo numerous toxicological tests before registration. One of these experiments is the examination of eye irritation potential. To get knowledge about eye irritation, recently only the in vivo Draize-test is accepted, which is one of the most criticized methods because of the injuries inflicted on the test animals. Several in vitro methods have been used to investigate the toxicity of potential eye irritants with a view to replacing in vivo eye irritation testing. In the HET-CAM test chemicals are placed in direct contact with chorioallantoic membrane of the hen's egg. The occurrence of vascular injury or coagulation in response to a compound is the basis for employing this technique as an indication of the likelihood that a chemical would damage mucous membranes (especially the eye) in vivo. In our studies comparative screening was performed with a set of agrochemicals to establish paralell data on in vitro (HET-CAM) and in vivo (Draize) results in case of 6 agrochemicals. The solutions to be tested are added to the membrane and left in contact for 5 minutes and the membrane is examined for vascular damage at set time periods. Irritancy is scored according to the severity and speed at which damage occurs providing an indication of the likely irritant effect of the compound. Our study showed good correlation between results obtained by the HET-CAM test and those of the Draize rabbit eye test most cases. The present form of the HET-CAM test can be proposed as a pre-screen method of eye irritation tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18399434

Source DB:  PubMed          Journal:  Commun Agric Appl Biol Sci        ISSN: 1379-1176


  8 in total

1.  Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.

Authors:  Purva Khare; Manasi M Chogale; Pratik Kakade; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2022-05-10       Impact factor: 5.671

2.  Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.

Authors:  Aimee Vasconcelos; Estefania Vega; Yolanda Pérez; María J Gómara; María Luisa García; Isabel Haro
Journal:  Int J Nanomedicine       Date:  2015-01-27

3.  Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.

Authors:  Gladys Rosario Ramos Yacasi; María Luisa García López; Marta Espina García; Alexander Parra Coca; Ana Cristina Calpena Campmany
Journal:  Int J Nanomedicine       Date:  2016-08-23

4.  Safety and efficacy of 4-terpineol against microorganisms associated with blepharitis and common ocular diseases.

Authors:  Chen-Wei Su; Sean Tighe; Hosam Sheha; Anny M S Cheng; Scheffer C G Tseng
Journal:  BMJ Open Ophthalmol       Date:  2018-06-04

5.  Evaluation of Eye Irritation Potential of Aqueous Leaf Extract of Achyranthes aspera by In Vitro and In Vivo Method.

Authors:  Gajanan Rajpal Deshmukh; Kuntrapakam Hema Kumar; Poojari Venkata Suresh Reddy; Boddapati Srinivasa Rao; Chirumamilla Venkata Satish Kumar
Journal:  ISRN Toxicol       Date:  2012-01-31

6.  Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy.

Authors:  Himanshu Gupta; Aqil Malik; R K Khar; Asgar Ali; Aseem Bhatnagar; Gaurav Mittal
Journal:  J Pharm Bioallied Sci       Date:  2015 Jul-Sep

7.  The Effect of Lamium album Extract on Cultivated Human Corneal Epithelial Cells (10.014 pRSV-T).

Authors:  Roman Paduch; Anna Woźniak
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep

8.  Polypseudorotaxanes of Pluronic® F127 with Combinations of α- and β-Cyclodextrins for Topical Formulation of Acyclovir.

Authors:  Cristina Di Donato; Rosa Iacovino; Carla Isernia; Gaetano Malgieri; Angela Varela-Garcia; Angel Concheiro; Carmen Alvarez-Lorenzo
Journal:  Nanomaterials (Basel)       Date:  2020-03-27       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.